PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

Inceptor Bio Enters into Collaboration with the University of Minnesota for the Development of iPSC Platform to Treat Cancer

Inceptor Bio Enters into Collaboration with the University of Minnesota for the Development of iPSC Platform to Treat Cancer

July 1, 2022

PharmaShots Weekly Snapshots (June 27 – July 01, 2022)

PharmaShots Weekly Snapshots (June 27 – July 01, 2022)

July 1, 2022

Sensorion’s SENS-401 Receives Australia’s Approval for the Initiation of Proof-of-Concept Trial to Treat Hearing Impairment

Sensorion’s SENS-401 Receives Australia’s Approval for the Initiation of Proof-of-Concept Trial to Treat Hearing Impairment

July 1, 2022

Pfizer Reports NDA Submission of Paxlovid to the US FDA for the Treatment of COVID-19

Pfizer Reports NDA Submission of Paxlovid to the US FDA for the Treatment of COVID-19

July 1, 2022

Sanofi Pauses Patient Enrollment in P-III Studies of Tolebrutinib for the Treatment of Multiple Sclerosis and Myasthenia Gravis in the US

Sanofi Pauses Patient Enrollment in P-III Studies of Tolebrutinib for the Treatment of Multiple Sclerosis and Myasthenia Gravis in...

July 1, 2022

Blueprint Medicines Signs $1.25B Agreement with Sixth Street & Royalty Pharma in Exchange for Royalties of Ayvakit and Gavreto

Blueprint Medicines Signs $1.25B Agreement with Sixth Street & Royalty Pharma in Exchange for Royalties of Ayvakit and Gavreto

July 1, 2022

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
[email protected]
Newsletter

Our Information

Follow Us